Trinity Biotech Plc Acquires Immco Diagnostics Inc.

Carter Ledyard client Trinity Biotech Plc acquired Immco Diagnostics Inc. (Immco) on July 26, 2013 for a consideration of $32.75m.  Headquartered in Buffalo, New York, and employing 90 people, Immco is a diagnostic company specializing in the development, manufacture and sale of autoimmune test kits on a worldwide basis.  This product line is complemented by specialized reference laboratory services in diagnostic immunology, pathology and immunogenetics, marketed to U.S.-based reference laboratories and hospitals. 
CL&M attorneys Alan J. Bernstein, Howard J. Barnet, Jr., Patricia Matzye, Bryan J. Hall, Natalie F. Wilmore and Katherine A. Mirett represented Trinity Biotech Plc in this transaction.

Latest News

See all news items

© Copyright 2020 Carter Ledyard & Milburn LLP